Published in Am J Ophthalmol on September 01, 2005
Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia. Br J Ophthalmol (2006) 1.21
Myopic choroidal neovascularisation: current concepts and update on clinical management. Br J Ophthalmol (2014) 1.02
Photodynamic monotherapy or combination treatment with intravitreal triamcinolone acetonide, bevacizumab or ranibizumab for choroidal neovascularization associated with pathological myopia. Indian J Ophthalmol (2011) 0.98
Intravitreal bevacizumab to treat myopic choroidal neovascularization: 2-year outcome. Graefes Arch Clin Exp Ophthalmol (2010) 0.88
Intravitreal bevacizumab versus photodynamic therapy for myopic choroidal neovascularization in a North-African population. Graefes Arch Clin Exp Ophthalmol (2011) 0.79
Outcome of photodynamic therapy in choroidal neovascularization due to pathologic myopia and related factors. Int Ophthalmol (2012) 0.76
Prognosis of untreated occult choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol (2006) 0.75
Effect of topical isopropyl unoprostone on macular atrophy progression in eyes with exudative age-related macular degeneration. Medicine (Baltimore) (2017) 0.75
Feasibility of intrasurgical spectral-domain optical coherence tomography. Retina (2011) 3.20
Posterior vitreomacular adhesion: a potential risk factor for exudative age-related macular degeneration? Am J Ophthalmol (2007) 2.82
Loss of reactivity in intravitreal anti-VEGF therapy: tachyphylaxis or tolerance? Br J Ophthalmol (2012) 2.38
The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology (2013) 2.35
A randomised double-masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration. Br J Ophthalmol (2013) 2.31
Adaptive designs for confirmatory clinical trials. Stat Med (2009) 2.30
Three-dimensional optical coherence tomography at 1050 nm versus 800 nm in retinal pathologies: enhanced performance and choroidal penetration in cataract patients. J Biomed Opt (2007) 2.02
Effect of photodynamic therapy on short-wavelength fundus autofluorescence in eyes with acute central serous chorioretinopathy. Retina (2015) 2.00
The advantages and disadvantages of adaptive designs for clinical trials. Drug Discov Today (2004) 1.87
Transplantation of autologous retinal pigment epithelium in eyes with foveal neovascularization resulting from age-related macular degeneration: a pilot study. Am J Ophthalmol (2002) 1.83
Transplantation of the RPE in AMD. Prog Retin Eye Res (2007) 1.81
Testing and estimation in flexible group sequential designs with adaptive treatment selection. Stat Med (2005) 1.80
Vitreomacular adhesion in active and end-stage age-related macular degeneration. Am J Ophthalmol (2009) 1.79
The impact of LH-containing gonadotropins on diploidy rates in preimplantation embryos: long protocol stimulation. Hum Reprod (2008) 1.73
A graphical approach to sequentially rejective multiple test procedures. Stat Med (2009) 1.71
Human retinal pigment epithelium (RPE) transplantation: outcome after autologous RPE-choroid sheet and RPE cell-suspension in a randomised clinical study. Br J Ophthalmol (2010) 1.63
Accuracy of preoperative biometry in vitrectomy combined with cataract surgery for patients with epiretinal membranes and macular holes: results of a prospective controlled clinical trial. J Cataract Refract Surg (2008) 1.61
Endophthalmitis with retinal necrosis following intravitreal triamcinolone acetonide injection. Ophthalmologica (2006) 1.60
Esophageal acid exposure in upright and recumbent postures: roles of lower esophageal sphincter, esophageal contractile and transport function, hiatal hernia, age, sex, and body mass. Dig Dis Sci (2006) 1.56
Multimodal photoacoustic and optical coherence tomography scanner using an all optical detection scheme for 3D morphological skin imaging. Biomed Opt Express (2011) 1.52
25-gauge vs 20-gauge system for pars plana vitrectomy: a prospective randomised clinical trial. Br J Ophthalmol (2007) 1.47
Minimum distance mapping using three-dimensional optical coherence tomography for glaucoma diagnosis. J Biomed Opt (2007) 1.34
Spectral-domain optical coherence tomography for monitoring epiretinal membrane surgery. Ophthalmology (2010) 1.34
Adaptive Dunnett tests for treatment selection. Stat Med (2008) 1.29
Selection and bias--two hostile brothers. Stat Med (2010) 1.24
Multispectral in vivo three-dimensional optical coherence tomography of human skin. J Biomed Opt (2010) 1.23
An adaptive hierarchical test procedure for selecting safe and efficient treatments. Biom J (2006) 1.19
Quality and reproducibility of retinal thickness measurements in two spectral-domain optical coherence tomography machines. Invest Ophthalmol Vis Sci (2011) 1.11
Correlation of different circulating endothelial progenitor cells to stages of diabetic retinopathy: first in vivo data. Invest Ophthalmol Vis Sci (2008) 1.10
Shrinkage estimation in two-stage adaptive designs with midtrial treatment selection. Stat Med (2012) 1.08
Non-responders to treatment with antagonists of vascular endothelial growth factor in age-related macular degeneration. Br J Ophthalmol (2013) 1.08
Vitrectomy for persistent diffuse diabetic macular edema. Am J Ophthalmol (2005) 1.06
Outcome of transplantation of autologous retinal pigment epithelium in age-related macular degeneration: a prospective trial. Invest Ophthalmol Vis Sci (2004) 1.06
Repeatability and reproducibility of retinal thickness measurements by optical coherence tomography in age-related macular degeneration. Ophthalmology (2010) 1.06
Choroidal blood flow and progression of age-related macular degeneration in the fellow eye in patients with unilateral choroidal neovascularization. Invest Ophthalmol Vis Sci (2010) 1.02
Update on ocular complications of systemic cancer chemotherapy. Surv Ophthalmol (2006) 1.01
Migraine and weather: a prospective diary-based analysis. Cephalalgia (2010) 1.00
Choroidal thickness in patients with reticular pseudodrusen using 3D 1060-nm OCT maps. Invest Ophthalmol Vis Sci (2014) 1.00
Predictors of mortality at initiation of peritoneal dialysis in children after cardiac surgery. Ann Thorac Surg (2004) 0.99
Conversion of Stratus optical coherence tomography (OCT) retinal thickness to Cirrus OCT values in age-related macular degeneration. Br J Ophthalmol (2011) 0.99
Sex-specific differences in glycemic control and cardiovascular risk factors in older patients with insulin-treated type 2 diabetes mellitus. Gend Med (2010) 0.99
Trends in primary retinal detachment surgery: results of a Bicenter study. Retina (2011) 0.99
Issues in designing flexible trials. Stat Med (2003) 0.98
Biological variation of the platelet proteome in the elderly population and its implication for biomarker research. Mol Cell Proteomics (2007) 0.97
Choroidal thinning in diabetes type 1 detected by 3-dimensional 1060 nm optical coherence tomography. Invest Ophthalmol Vis Sci (2012) 0.97
What affects the recurrence and clinical outcome of pigmented villonodular synovitis? Clin Orthop Relat Res (2006) 0.96
Heterogeneous pattern of retinal nerve fiber layer in multiple sclerosis. High resolution optical coherence tomography: potential and limitations. PLoS One (2010) 0.94
Enhanced serotonin transporter function during depression in seasonal affective disorder. Neuropsychopharmacology (2007) 0.93
Epimacular brachytherapy for neovascular age-related macular degeneration: a randomized, controlled trial (CABERNET). Ophthalmology (2012) 0.93
Half-fluence photodynamic therapy in chronic central serous chorioretinopathy. Retina (2013) 0.92
Spectral domain high-definition optical coherence tomography in patients undergoing epiretinal membrane surgery. Ophthalmic Surg Lasers Imaging (2009) 0.92
Reading ability and central visual field after photodynamic therapy. Ophthalmologica (2004) 0.90
Reproducibility and comparison of retinal thickness and volume measurements in normal eyes determined with two different Cirrus OCT scanning protocols. Retina (2011) 0.90
Opportunities and challenges of combined effect measures based on prioritized outcomes. Stat Med (2013) 0.90
Central retinal vein occlusion as a possible presenting manifestation of Sneddon syndrome. J Neuroophthalmol (2007) 0.89
Automated three-dimensional choroidal vessel segmentation of 3D 1060 nm OCT retinal data. Biomed Opt Express (2012) 0.89
Half-fluence photodynamic therapy in acute central serous chorioretinopathy. Retina (2012) 0.89
INTRASURGICAL MICROSCOPE-INTEGRATED SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY-ASSISTED MEMBRANE PEELING. Retina (2015) 0.89
Mcl-1, vascular endothelial growth factor-R2, and 14-3-3sigma expression might predict primary response against radiotherapy and chemotherapy in patients with locally advanced squamous cell carcinomas of the head and neck. Clin Cancer Res (2005) 0.88
A prospective, randomised, multicenter trial for surgical treatment of central retinal vein occlusion: results of the Radial Optic Neurotomy for Central Vein Occlusion (ROVO) study group. Graefes Arch Clin Exp Ophthalmol (2012) 0.87
Scaffolds for retinal pigment epithelium (RPE) replacement therapy. Br J Ophthalmol (2011) 0.87
Amniotic membrane maintains the phenotype of rabbit retinal pigment epithelial cells in culture. Exp Eye Res (2005) 0.87
Role of amiodarone on the systemic inflammatory response induced by cardiac surgery: proinflammatory actions. Can J Anaesth (2007) 0.87
Surgical embolus excision in retinal artery occlusion - two case reports. Acta Ophthalmol (2013) 0.86
Reduction of iatrogenic RPE lesions in AMD patients: evidence for wound healing? Graefes Arch Clin Exp Ophthalmol (2007) 0.86
Circulating angiopoietic cells and diabetic retinopathy in type 2 diabetes mellitus, with or without macrovascular disease. Invest Ophthalmol Vis Sci (2011) 0.86
Headache, menstruation and combined oral contraceptives: a diary study in 184 women with migraine. Eur J Pain (2011) 0.86
Activation of the beta-catenin signaling pathway and its impact on RPE cell cycle. Invest Ophthalmol Vis Sci (2009) 0.85
Quality of the threshold algorithm in age-related macular degeneration: Stratus versus Cirrus OCT. Invest Ophthalmol Vis Sci (2008) 0.85
Cirrus OCT versus Spectralis OCT: differences in segmentation in fibrovascular pigment epithelial detachment. Graefes Arch Clin Exp Ophthalmol (2010) 0.85
Spectral domain optical coherence tomography for higher precision in the evaluation of vitreoretinal adhesions in exudative age-related macular degeneration. Br J Ophthalmol (2011) 0.85
Efficacy of intravitreal bevacizumab (Avastin) therapy for early and advanced neovascular age-related macular degeneration. Acta Ophthalmol (2009) 0.85
The effect of specific gravity of perfluorocarbon liquid on the retina after experimental vitreous substitution. Graefes Arch Clin Exp Ophthalmol (2004) 0.84
Epidermal growth factor inhibits glycogen synthase kinase-3 (GSK-3) and beta-catenin transcription in cultured ARPE-19 cells. Graefes Arch Clin Exp Ophthalmol (2007) 0.84